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Sepsis is the third most common cause of death among neonates, with about 225,000 new-
borns dying every year globally. Data concerning the microbial etiology of neonatal sepsis
and antimicrobial resistance profiles of its causative agents are necessary to inform targeted
and effective treatment and prevention strategies.
Objective
To determine the proportion of newborns with symptoms and signs of sepsis who had a pos-
itive blood culture, its bacterial etiology, the antimicrobial resistance patterns as well as the
factors associated with culture-positivity and case fatality at Mulago national referral hospital
in Uganda.
Methods
We conducted a cross-sectional study among 359 neonates with symptoms and signs of
sepsis who presented to the pediatric emergency care unit of Mulago national referral hospi-
tal from mid-January to end of December 2018. We performed blood culture and antimicro-
bial susceptibility testing, and conducted polymerase chain reaction to identify methicillin-
resistant Staphylococcus aureus (MRSA) isolates. We used multivariable logistic regression
to estimate the association between potential risk factors and culture-positive neonatal
sepsis.
Findings
Of the 359 neonates recruited, 46 (12.8%; 95% CI 9.5%, 16.7%) had a positive blood cul-
ture. The predominant isolated bacteria were Staphylococcus aureus in 29 (63.0%),
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Escherichia coli in seven (15.2%), and Klebsiella pneumoniae in five (10.9%). Of the 46
pathogens, 73.9% were resistant to ampicillin, 23.9% to gentamicin and 8.7% to ceftriaxone.
We isolated MRSA from the blood specimens of 19 (5.3%) of the 359 neonates, while 3
(0.8%) grew extended spectrum beta lactamase producers. The case fatality risk among
neonates with neonatal sepsis was 9.5% (95% CI: 6.6%, 13.0%). Cesarean section delivery
was strongly associated with culture-positive sepsis (adjusted odds ratio 3.45, 95% CI: 1.2,
10.1).
Conclusion
One in eight neonates with clinical signs of sepsis grew a likely causative bacterial patho-
gen. S. aureus was the main pathogen isolated and a third of these isolates were MRSA. A
significant proportion of the isolated bacterial pathogens were resistant to the first and sec-
ond line antibiotics used for the treatment of neonatal sepsis. There is need to revisit the cur-
rent treatment guidelines for neonatal sepsis.
Introduction
The mortality among children less than 5 years of age has declined considerably over the last
two decades, but neonatal mortality remains high, accounting for 2.6 million annual deaths[1].
Uganda has a neonatal mortality of 22.3 deaths per 1,000 live births which is one of the highest
in the world[2]. Severe infections are the leading cause and accounts for approximately one-
third of newborn deaths in sub-Saharan Africa[3]. Among survivors, neonatal sepsis may be
accompanied by long-term complications such as neurodevelopmental impairment[4]. To
achieve the third sustainable development goal of reducing neonatal mortality to under 12
deaths per 1,000 live births, a better understanding of the etiology of neonatal sepsis is needed.
Important signs and symptoms of neonatal sepsis include inability to breastfeed, convul-
sions, fast breathing, severe lower chest wall in-drawing, lethargy, fever and hypothermia[5].
Neonatal sepsis is a clinical syndrome including septicemia and meningitis that is classified
according to disease onset[6]. Early-onset sepsis (EOS) is defined as disease among neonates
aged 72 hours or less while late-onset sepsis occurs from 4 to 28 days[6]. Early-onset sepsis
usually results from an infection acquired in utero or during the birth process and group B
Streptococcus(GBS) is the most common pathogen causing EOS in high income countries
whereas Staphylococcus aureus, Klebsiella species and Escherichia coli are the most common
causes in low and middle income-countries[7–9]. In low and middle income countries, late-
onset sepsis is usually a result of infection from the surrounding environment (hospital or
community) and the incriminated pathogens are majorly gram negative bacteria including E.
coli, Klebsiella pneumoniae, Acinetobacter spp., Pseudomonas aeruginosa; as well as S. aureus
[10–12]. However, the pathogen profile differs depending on the region. There is a predomi-
nance of gram negative pathogens and low prevalence of GBS in south Asia and sub-Saharan
African compared to the high GBS prevalence in high income countries[10, 11, 13]. Surveil-
lance of the etiology of neonatal sepsis and resistance patterns of the causative bacteria is criti-
cally important in informing the empirical treatment of neonatal sepsis and in guiding the
development of preventive strategies, including the development and deployment of vaccines.
This information is particularly important in resource-limited settings where access to blood
cultures is limited and if available, often unaffordable.
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In Uganda, neonatal sepsis is managed according to the Uganda Clinical Guidelines, which
recommend ampicillin and gentamicin as first-line and third-generation cephalosporins as
second-line treatment[14]. Although previous studies[15–17] have reported on neonatal sepsis
in Uganda, data on the etiology and antimicrobial resistance patterns of the causative bacteria
is limited. There is a need to carefully characterize bacterial pathogens from blood cultures of
neonates with clinical signs of sepsis because antibiotic susceptibility profiles of the causative
organisms change over time[18]. In this study, we aimed to determine the bacterial etiology of
culture-positive sepsis and antimicrobial resistance patterns. We also estimated the case fatality
risk of neonatal sepsis and factors associated with culture-positive sepsis at Mulago national
referral hospital.
Methods
Study design and setting
We conducted a hospital-based cross-sectional study at the pediatric emergency care unit of
Mulago national referral hospital from January to December 2018. Mulago is the largest ter-
tiary hospital in Uganda, has an average of 100 births per day and its pediatric emergency care
unit admits an average of 20 newborns per week. It is the teaching hospital for Makerere Uni-
versity College of Health Sciences, located in Kampala, the capital city of Uganda. The pediat-
ric emergency care unit admits critically ill children for up to 24 hours before they are
transferred to the general pediatric wards.
Participants
We included neonates, i.e. babies less than 29 days of age, who presented with any of the fol-
lowing symptoms and signs during daytime (i.e. 8:00hrs to 17:00hrs) on weekdays: inability to
breastfeed, convulsions, fast breathing (more than 60 breaths per minute), severe lower chest
in-drawing, lethargy, fever (axillary temperature�37.5˚C) and low body temperature (axillary
temperature<35.5˚C) according to the integrated management of childhood illnesses (IMCI)
guidelines[19]. We decided to exclude neonates with severe congenital anomalies from the
study and those that reported during the night (after 18:00hrs) and (or) during the weekends
(Saturday and Sunday).
Sample size estimation
The sample size was calculated based on the main objective, which was to estimate the propor-
tion of newborns with culture-positive sepsis among children admitted with clinical signs of
sepsis. Based on the following assumptions; 95% confidence interval, prevalence of culture
proven septicemia 37%[17] and precision 5%, we needed a sample size of 359 newborns with
clinical sepsis.
Study procedure and informed consent
We enrolled neonates who presented with symptoms and signs of sepsis upon admission at
the emergency pediatric unit. A trained nurse obtained written informed consent and used
validated pretested questionnaires to capture information on demographic and clinical charac-
teristics from mothers or other primary caretakers of the study participants. We collected
information on the presence of the following symptoms and signs: inability to feed, convul-
sions, fast breathing, severe lower chest wall in-drawing, lethargy, fever, hypothermia, umbili-
cal cord stump infection and skin pustules. We also recorded data on the mode of delivery,
birth weight, sex of the child, gestational length, antibiotic use before admission, prior
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hospitalization and its duration. Mothers or caretakers of participants were asked about a his-
tory of fever, foul smelling vaginal discharge during their last trimester of pregnancy and pre-
mature rupture of membranes. We followed up the participants until they were discharged
and collected information which included the length of hospitalization, antibiotics used for
treating current illness and immediate clinical outcomes which was defined as either death or
recovery.
Blood specimen collection
Three milliliters of venous blood were drawn aseptically from the participants before the
administration of antibiotics. Two milliliters of the blood were inoculated into pediatric blood
culture bottles (BD BactecTM Peds PlusTM/F) for culture. The specimens were transported
daily to MBN Clinical Laboratories[20].
Laboratory methods
Blood culture. Blood culture bottles were incubated in an automated incubator (BD BAC-
TEC™FX40, USA) at 37˚C for 24 hours. Bottles that indicated absence of bacteria in BACTEC
were incubated for five more days before considering them negative. When a bottle was
flagged positive, blood culture aliquots were sub cultured on blood, chocolate and MacConkey
agar (BioLab Budapest, Hungary) and incubated at 35˚C to 37˚C for up to 96 hours.
Identification of bacterial species. Identification of bacterial species was done based on
colony morphology, Gram stain appearance and standard biochemical tests[21]. All isolates
were stored in 20% glycerol in Brain Heart Infusion broth at -80˚C for subsequent molecular
identification of methicillin resistant Staphylococcus aureus (MRSA).
Drug susceptibility testing. Antimicrobial susceptibility testing was performed on the
Mueller-Hinton agar using the disk diffusion method as per the Clinical Laboratory Standard
Institute (CLSI) guidelines[22]. A lawn culture was made on Muller-Hinton agar plate on
which the antibiotic disks were placed and incubated between 35 oC to 37˚C for 24 hours. The
D-test was performed to detect the presence of erythromycin-induced clindamycin resistance
among S. aureus isolates as previously described[23]. We screened Enterobacteriaceae isolates
for ESBL resistance using the combination disk method as previously described[24, 25].
Detection of mecA gene for the identification of MRSA: Methicillin-resistant S. aureus
(MRSA) was detected using polymerase chain reaction for the mecA gene as previously
described[26].
Quality control. Standard aseptic methods of blood collection and processing were
adhered to. S. aureus ATCC 25923 was used to quality control S. aureus isolates, E. coli ATCC
25922 for lactose fermenting bacteria and P. aeruginosa ATCC 27853 for non-lactose ferment-
ing bacteria. For genotyping, ATCC 25923 (mecA-negative) and an in-house S. aureus mecA-
positive strain were used to control for the mecA gene.
Study variables
The main outcome of the study was culture-positive sepsis. A positive blood culture was
defined by the isolation of at least one of the following potential pathogens; S. aureus, E. coli,
K. pneumoniae, S. pneumoniae, N. meningitides, Group B streptococcus, Streptococcus pyogenes,
C. freundii, Enterococcus spp., Salmonella spp., Acinetobacter spp., Pseudomonas spp. and
Enterobacter spp. A negative blood culture was defined by the absence of bacterial growth or
the isolation of possible contaminants such as Corynebacterium spp., Bacillus spp. and coagu-
lase-negative Staphylococcus species. Secondary outcomes included: antibiotic resistance pro-
files of the isolated pathogens and death of the newborns participating in the study. Other
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variables used to describe the participants or adjust our estimates were birth weight (dichoto-
mized into low birth weight, i.e. less than 2.5 kg, and normal birth weight, i.e. 2.5 kg or more),
age of the newborn, premature rupture of membranes (PROM), umbilical cord stump infec-
tion, lethargy, hypothermia, fever, inability to breastfeed, initiation of breastfeeding, previous
antibiotic use, re-admission, length of hospitalization, current treatment and presence of resis-
tant pathogens in blood.
Statistical analysis
We entered data doubly into EPI-Data version 13 and data analysis using STATA 15.0 (Stata-
Corp, College Station, Tx, USA). We summarized categorical variables as proportions and
described continuous variables using means and their standard deviations (SD). We per-
formed crude and multivariable logistic regression analysis to assess factors associated with
culture-positive sepsis. Crude odds ratios (OR) and 95% confidence intervals (95% CI) were
estimated for each exposure variable. Based on previous literature, we decided to include the
following variables in our multivariable model; PROM, maternal fever in the last trimester and
mode of delivery[27, 28]. Other variables we included were birth weight, umbilical cord infec-
tion, prior antibiotic use, foul-smelling vaginal discharge, maternal age and education back-
ground. To assess the association between culture-positivity and risk of subsequent death, we
estimated the corresponding risk ratio (RR) with a generalized linear model of the binomial
family with a log link. Based on existing literature[29, 30], we adjusted the RR for antibiotic
treatment before admission, whether the sepsis was of early or late onset, re-admission for the
current illness, and mode of delivery.
Ethical approval and consent to participate
We obtained ethical approval from the Mulago National Referral Hospital Research and Ethics
Review Committee (MHREC-1069) and written informed consent from parents/primary care-
takers of the neonates enrolled in the study.
Results
Description of study participants
None of the neonates considered for inclusion had severe congenital anomalies and, among
the 596 babies suspected of having clinical sepsis, we recruited 359 neonates that met our pre-
defined IMCI criteria. Their mean age at admission and recruitment was 8 (SD 7.1) days;
about half(53%) of them were admitted within their first, another 27% in their second week of
life. Their mean birth weight was 3.1 kg (SD 0.6) and the median duration of hospitalization
was 5.4 (IQR 4, 6) days. The mothers of the enrolled neonates had a mean age of 26 years (SD
5.5). Other maternal factors included: fever in the last trimester 105 (29.2%) and foul-smelling
vaginal discharge 89 (24.8%) (Table 1).
Bacterial etiology
Of the 359 neonates, 46 (12.8%; 95% CI 9.5%, 16.7%) had a positive blood culture and we did
not identify more than one bacterial pathogen in any of them. Of the 46 babies, 15 (32.6%) had
early-onset, whereas 31 (67.4%) had late-onset sepsis. Gram-positive bacteria constituted 70%
(32/46) of all isolates of which 90.6% (29/32) were S. aureus. Other gram-positive organisms
included S. pneumoniae 2.2% (1/46) and Enterococcus spp. 4.3% (2/46). The remaining 30%
(14/46) were gram-negative organisms which included seven E. coli isolates, five K. pneumo-
niae isolates, and one Neisseria spp. and C. freundii isolate (Table 2). We isolated likely
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Table 1. Demographic and clinical characteristics of neonates with clinical sepsis at Mulago national referral
hospital.
Culture positive sepsis
Yes 46 (%) No 313 (%) N = 359 (%)
Neonatal characteristics
age (days)
0 to 3 (early onset) 15 (32.6) 110 (35.1) 125 (34.8)
4 to 28 (late onset) 31 (67.4) 203 (64.9) 234 (65.2)
Sex
Male 23 (50.0) 178 (57.1) 201 (56.2)
Female 23 (50.0) 134 (42.9) 157 (43.8)
Birth weight
Low 5 (10.9) 43 (13.7) 48 (13.4)
Normal 41 (89.1) 270 (86.3) 311 (86.6)
Inability to breast feed
No 23 (50.0) 163 (52.1) 186 (51.8)
Yes 23 (50.0) 150 (47.9) 173 (48.2)
Fever
No 14 (30.4) 112 (35.8) 126 (35.1)
yes 32 (69.6) 201 (64.2) 233 (64.9)
Difficulty in breathing
No 32 (69.6) 219 (70.0) 251 (70.0)
Yes 14 (30.4) 94 (30.0) 108 (30.1)
Convulsions
No 36 (78.3) 266 (85.0) 302 (84.1)
Yes 10 (21.7) 47 (15.0) 57 (15.9)
Lethargy
No 35 (76.1) 268 (85.6) 303(84.4)
Yes 11 (23.9) 45 (14.4) 56 (15.6)
Umbilical cord infection
No 38 (82.6) 246 (78.6) 284 (79.1)
Yes 8 (17.4) 67 (21.4) 75 (20.9)
Prior antibiotic use
No 34 (73.9) 221 (71.5) 255 (71.8)
Yes 12 (28.5) 88 (28.5) 100 (28.2)
Maternal characteristics
Age (Years)
Less than 20 6 (13.0) 26 (8.3) 32 (8.9)
20–24 17 (37.0) 120 (38.3) 137 (38.2)
25–29 13 (28.7) 90 (28.8) 103 (28.7)
30 or more 10 (21.7) 77 (24.6) 87 (24.2)
Education
Primary 17 (37.0) 105 (33.8) 122 (34.2)
Secondary 23 (50) 170 (54.7) 193 (54.0)
Tertiary 6 (13.0) 36 (11.6) 42 (11.8)
Mode of delivery
Spontaneous vaginal delivery 23 (50) 195 (62.7) 218 (61.1)
Assisted vaginal delivery 17 (37.0) 99 (31.8) 116 (32.5)
Caesarean section 6 (13.0) 17 (5.5) 23 (6.4)
(Continued)
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contaminants from about 2% (7/359) of the neonates. The likely contaminants included 2
Bacillus spp., 4 Corynebacteria spp., and one isolate of coagulase-negative Staphylococcus.
Antimicrobial resistance profiles of isolated bacteria
We found that among the 46 neonates with a positive blood culture, resistance to first-line
antibiotics was identified in ampicillin 39 (84.8%) and gentamicin in 11 (23.9%), while resis-
tance to second-line 3rd generation cephalosporins was identified in 4 (8.7%). Overall, the pro-
portions of babies with likely causative bacteria that were resistant to first-line and to second-
line antibiotics were 13.9% (50/359, 95% CI; 10.5, 17.9) and 1.1% (4/359, 95% CI; 0.3, 2.8)
respectively. Two thirds of the babies who had blood cultures with S. aureus had MRSA, while
erythromycin-induced clindamycin-resistant S. aureus were observed in31%. All the S. aureus
isolates were susceptible to vancomycin. Forty-one percent (19/46; 95% CI 27.0%, 56.8%) of
the babies with culture-positive sepsis had MRSA. Overall, the proportion of participants with
MRSA was 5.3% (19/359; 95% CI 3.2%, 8.1%).
All K. pneumoniae and six E. coli isolates were resistant to ampicillin. Resistance to genta-
micin was observed in two (28.6%) of seven E. coli isolates and in two (40%) of five K. pneumo-
niae isolates. Three of the K. pneumoniae isolates, one E. coli and one Neisseria spp. isolates
were resistant to third-generation cephalosporins (ceftriaxone and ceftazidime). All gram-neg-
ative bacteria isolated in this study were susceptible to the carbapenem class of antibiotics
Table 1. (Continued)
Culture positive sepsis
Yes 46 (%) No 313 (%) N = 359 (%)
Marital status
Unmarried 6 (13.0) 32 (10.2) 38 (10.6)
Married 40 (87.0) 281 (89.8) 321 (89.4)
Fever in pregnancy
No 38 (82.6) 216 (69.0) 254 (70.7)
Yes 8 (17.4) 97 (31.0) 105 (29.3)
Foul vaginal discharge
No 32 (69.6) 238 (76.0) 270 (75.2)
Yes 14 (30.4) 75 (24.0) 89 (24.8)
Prolonged rupture of membranes
No 34 (73.9) 199 (63.6) 232 (64.9)
Yes 12 (26.1) 114 (36.4) 126 (35.1)
https://doi.org/10.1371/journal.pone.0237085.t001
Table 2. Bacterial pathogens isolated from blood of neonates with symptoms and signs sepsis at Mulago national
referral hospital.
Bacteria Isolated Overall (%) Early onset (0–3 days) Late onset (4-28days)
S. aureus 29 (8.1) 13 (7.0) 16 (10.0)
E. coli 7 (2.0) 5 (2.7) 2 (1.2)
K. pneumoniae 5 (1.4) 3 (1.6) 2 (1.2)
Enterococcus spp. 2 (0.6) 2 (1.1) 0
Neisseria spp. 1 (0.3) 0 1 (0.6)
S. pneumoniae 1 (0.3) 0 1 (0.6)
C. freundii 1 (0.3) 0 1 (0.6)
Total 46 23 23
https://doi.org/10.1371/journal.pone.0237085.t002
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(Table 3). However, three bacterial pathogens phenotypically exhibited ESBL resistance trans-
lating to a proportion of 6.5% (3/46; 95%CI 1.4%, 17.9%) among neonates with positive-cul-
ture sepsis. Enterobacteriaceace that exhibited carbapenem resistance included one E. coli and
three K. pneumoniae isolates. Overall, the proportion of the neonates with MRSA was 5.3%
(19/359; 95% CI 3.2%, 8.1%), with ESBL producers 0.8% (3/359; 95% CI 0.02%, 2.4%) and with
carbapenem resistance 1.1% (95% CI 0.3%, 2.8%).
Factors associated with culture-positive sepsis
The odds of being born by caesarian section among neonates with culture-positive sepsis was
three times that among babies born by spontaneous vaginal delivery (AOR 3.45, 95% CI;
1.19,10.05). Subgroup analysis yielded similar findings (Table 4).
Immediate clinical outcomes
Of the 359 neonates with symptoms and signs of sepsis, 34 died, translating to a case fatality
risk of 9.5% (95% CI; 6.6%, 13.0%). The case fatality risk for culture-positive sepsis was 15.2%
(7/46; 95% CI 6.3%, 28.9%) in comparison to 8.6% (27/313; 95% CI 5.8%, 12.3%) among the
culture negative participants. After adjusting for previous antibiotic use, age, re-admission and
mode of delivery, the odds of death among neonates with culture-positive sepsis were 1.6
times higher than that among those with culture-negative sepsis (adjusted RR 1.60; 95% CI
0.66, 4.0).
Of the 34 neonates that died, 25 (73.5%) were treated with only first-line antibiotics (ampi-
cillin and gentamicin) while 9 (32.4%) were treated with second-line antibiotics (ceftazidime,
ceftriaxone and cefixime). Pathogens isolated from newborns that died included three S.
aureus isolates (two of which were MRSA), two E. coli isolates (one of which was an ESBL pro-
ducer), one ESBL producing K. pneumoniae isolate and one C. freundii isolate. Regarding the
length of hospitalization among those who died, 30 neonates were hospitalized for�5 days,
two neonates for 14 days, one for 16 and one for 18 days.
Table 3. Antimicrobial resistance profile of pathogens isolated from neonates with symptoms and signs of sepsis at Mulago national referral hospital between Janu-
ary and December 2018.
Antibiotics All participants Neonates with culture-positive sepsis S. aureus E. coli K. pneumoniae
N = 359 (%) n = 46 (%) n = 29 n = 7 n = 5
Erythromycin 21 (5.8) 21 (45.7) 21(72.4) NA NA
Vancomycin 0 0 0 NA NA
Tetracycline 13 (3.6) 13 (28.3) 13 (44.8) NA NA
Penicillin 28 (7.8) 28 (60.9) 28 (96.6) NA NA
Gentamicin 11 (3.1) 11 (23.9) 7(24.1) 2 (28.6) 2 (40.0)
Trimethroprim-Sulphamethoxazole 34 (9.5) 34 (73.9) 27 (93.1) 4 (57.1) 3 (60)
Chloramphenicol 8 (2.2) 8 (17.4) 7 (15.2) 0 1 (2.2)
Ampicillin 39 (10.9) 39 (84.8) 28 (96.6) 6 (85.7) 5 (100.0)
Amoxycillin-clavulanic acid 9 (2.5) 9 (19.6) NA 5 (71.4) 4 (80.0)
Ceftazidime� 4 (1.1) 4 (8.7) NA 1 (14.3) 3 (60)
Ceftrioxone� 4 (1.1) 4 (8.7) NA 1 (14.3) 3 (60)
Cefuroxime� 4 (1.1) 4 (8.7) NA 1 (14.3) 3 (60)
Imipenem� 4 (1.1) 4 (8.7) NA 1 (14.3) 3 (60)
�The four isolates (resistant to these antibiotics) are the same.
https://doi.org/10.1371/journal.pone.0237085.t003
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Discussion
This study aimed to determine the proportion of neonates admitted with signs and symptoms
of clinical sepsis to the pediatric department of the Ugandan national referral hospital in Kam-
pala who had a positive blood culture. It aimed to also describe the etiology of culture-positive
sepsis in these newborns and the antimicrobial resistance profiles of isolated bacteria and the
factors associated with culture-positive sepsis.
Table 4. Neonatal and maternal factors potentially associated with culture-positive sepsis among neonates with symptoms and signs sepsis at Mulago national
referral hospital.














0 to 3 1 - - - - -
4 to 28 1.12 (0.58, 2.16) - - - - -
Birth weight
Normal 1 1 1 1 1 1
Low 0.77 (0.29, 2.05) 0.84 (0.30, 2.31) 1.03 (0.29, 3.71) 1.35 (0.34, 5.31) 1.29 (0.43, 3.88) 0.91 (0.29, 2.89)
Umbilical cord infection
No 1 - 1 1 1 -
Yes 0.77 (0.34, 1.74) - 0.59 (0.21, 1.63) 0.55 (0.18, 1.66) 0.62 (0.26, 1.47) -
Prior antibiotic use
No 1 - 1 - 1 -
Yes 0.79 (0.46, 1.36) - 0.80 (0.33, 1.94) - 0.88 (0.55, 1.43) -
Maternal characteristics
Age (Years)
Less than 20 1.63 (0.59, 4.53) 1.43 (0.49, 4.18) 0.69 (0.14, 3.38) 0.59 (0.11, 3.11) 1.33 (0.44, 4.01) 1.17 (0.38, 3.65)
20–24 (Reference group) 1 1 1 1 1 1
25–29 1.02 (0.47, 2.21) 1.0 (0.45, 2.22) 0.71 (0.25, 2.00) 0.67 (0.22, 2.09) 0.80 (0.34, 1.85) 0.74 (0.31, 1.78)
30 or more 0.92 (0.40, 2.11) 0.74 (0.30, 1.79) 0.78 (0.27, 2.22) 0.52 (0.16, 1.66) 0.85 (0.36, 2.04) 0.74 (0.29, 1.88)
Education
Primary 1.03 (0.38, 2.79) 1.11 (0.39, 3.19) 1.17 (0.29, 4.67) 1.39 (0.31, 6.21) 1.12 (0.38, 3.34) 1.19 (0.38, 3.76)
Secondary 0.86 (0.33, 2.25) 0.89 (0.30, 1.79) 1. 11(0.30, 4.16) 1.14 (0.27, 4.72) 0.99 (0.35, 2.84) 1.00 (0.33, 3.03)
Tertiary 1 1 1 1 1 1
Mode of delivery
Spontaneous vaginal delivery 1 1 1 1 1
Assisted vaginal delivery 1.47 (0.75, 2.88) 1.59 (0.79, 3.18) 1.54 (0.64, 3.71) 1.82 (0.70, 4.76) 1.30 (0.63, 2.66) -
Caesarean section 3.02 (1.10, 8.43) 3.45 (1.19, 10.05) 3.58 (0.84, 15.17) 4.45 (0.92, 21.52) 2.78 (0.81, 9.61) -
Fever in pregnancy
No 1 1 1 1 1 1
Yes 0.47 (0.21, 1.04) 0.47 (0.21, 1.07) 0.28 (0.08, 0.96) 0.20 (0.05, 0.76) 0.44 (0.19, 1.04) 0.37 (0.15, 0.91)
Foul vaginal discharge in
pregnancy
No 1 1 1 1 1 1
Yes 1.18 (0.84, 1.66) 1.30 (0.90, 1.88) 1.27 (0.83, 1.95) 1.53 (0.94, 2.48) 1.18 (0.83, 1.69) 1.43 (0.97, 2.12)
PROM
No 1 1 1 1 1 1
Yes 0.61 (0.31, 1.22) 0.53 (0.25, 1.11) 0.53 (0.21, 1.31) 0.46 (0.17, 1.25) 0.58 (0.27, 1.26) 0.47 (0.21, 1.04)
�Analysis restricted to 0–7 and 0–14 day old babies.
https://doi.org/10.1371/journal.pone.0237085.t004
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The predominate pathogens isolated from neonates with symptoms and signs of sepsis
were S. aureus, E. coli and K. pneumoniae. Our findings were similar to those from previous
studies in East Africa[5, 31]. Unlike our study, Klebsiella spp. and K. pneumoniae were the
most commonly isolated bacterial species in blood drawn from neonates with clinical sepsis in
a hospital-based Zambian study, possibly explained by a nosocomial outbreak[32]. Generally,
many African studies report gram-positive bacteria, especially S. aureus, as the main cause of
neonatal sepsis; a situation very different from that in South Asia where gram-negative bacte-
ria, especially Acinetobacter spp. and K. pneumoniae seem to be the main cause[10, 33]. The
predominance of S. aureus among neonates with culture-positive sepsis in our study may indi-
cate vertical transmission, more so because this pathogen was also common among babies
with early onset sepsis.
We observed resistance to antibiotics (ampicillin, gentamicin and ceftriaxone) commonly
used to treat neonatal sepsis. Ampicillin and gentamicin were the first-line antibiotics used to
treat almost all of the neonates in our study. Among the bacterial pathogens isolated from the
blood of participants, we observed almost three quarters were resistant to ampicillin and
almost one quarter to gentamicin. This is similar to what other studies in Tanzania[31], Ethio-
pia[34] and Zambia[32] have reported. The resistance patterns observed in our study are not
surprising because the pathogens adapt to selection pressure exerted by the misuse of common
antibiotics[35]. K. pneumoniae and E. coli isolates have intrinsic antimicrobial resistance
mechanisms which include chromosomally encoded antibiotic inactivating enzymes or efflux
pumps; that enable the many gram-negative bacteria to exhibit such resistance to ampicillin/
penicillin antibiotics[36].
Our findings are comparable to those in Kenya[37] and Nigeria[38, 39]. On the contrary, a
Ugandan study previously conducted at the Mulago hospital reported resistance among the
bacterial pathogens to gentamicin to be lower than that in our study[17]. Since that study was
conducted more than 15 years ago from the same hospital as our study, the differences
observed between the findings may be explained by a remarkable and worrying acquisition of
antimicrobial resistance genes among important invasive bacterial pathogens. Four of 14
(29%) gram-negative pathogens in our study were resistant to third-generation cephalospo-
rins. The proportions of resistance to third-generation cephalosporin in our study were similar
to those observed in other African studies[34, 40].
ESBL producers accounted for 6.5% of the isolated pathogens. Other studies in low-income
settings reported proportions of ESBL pathogens ranging from 10.5% to 25% among patho-
gens from neonates with sepsis[41–44]. Although the proportion of ESBL producing bacteria
was relatively low in our study, it was imprecisely estimated, and their isolation in the blood of
neonates with sepsis is important. This is because ESBL pathogens are associated with long
hospitalization stays and death[45, 46]. In-fact, two of the 3 neonates with ESBL in this study
died.
Most of the S. aureus strains isolated in this study were methicillin resistant. The high pro-
portion of MRSA among S. aureus isolates suggests the possibility of transmission from the
colonized maternal genital tract or transmission from the labour ward and neonatal units after
unhygienic personal or obstetric practices. Susceptible S. aureus bacteria adapt to antimicro-
bial pressure through the acquisition of mobile genetic elements carrying antimicrobial resis-
tance genes from other bacteria encoding modified penicillin binding protein 2a which has
very low affinity for beta-lactam drugs[47].
In this study, we found that the odds of developing culture-positive sepsis among neonates
born through cesarean section were three times that of those born through vaginal delivery.
Although statistically imprecise, our findings are similar to those from other studies[34, 48]
that found cesarean-section to be associated with neonatal sepsis. This finding is not
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surprising, especially in settings with poor infection control practices. In addition, this associa-
tion may be explained by underlying indications for cesarean-section such as obstructed
labour, premature rapture of membranes and prolonged labor. The immature immune system
of neonates puts them at high risk of infection, especially those born prematurely or with low
birth weight and who are not breastfeeding[49]. In contrast to other studies[50, 51], we did not
find strong associations between low birth weight, premature rupture of membranes and cul-
ture-positive neonatal sepsis.
Strengths and limitations
Recruiting neonates from the national referral hospital over a one-year period may be a rela-
tively good representation of neonates with clinical symptoms and signs of sepsis in Kampala
and the surrounding areas. However, our study was too small to yield statistically precise esti-
mates for the less common pathogens and for the resistance patterns for the less common
ones. Further, it had inadequate power to fully explore the association between the exposures
and neonatal sepsis. As most other studies, we will have underestimated the proportion of neo-
nates with neonatal septicemia, both because blood culture in itself has a poor sensitivity[52]
and because we did not collect cerebrospinal fluid to diagnose meningitis.
Conclusion
An eighth of neonates admitted to the national referral hospital with clinical signs of sepsis
had a positive blood culture. S. aureus was the most commonly isolated pathogen, and two-
thirds of such isolates were MRSA. Resistance to first-line antibiotics used for the management
of sepsis was common. Our neonates with culture-positive sepsis had a high case fatality risk,
and there is therefore an urgent need for quick and accurate diagnostic tools for systemic bac-
terial infections in neonates. Our and others’ findings that caesarian section seems to be associ-
ated with culture-positive sepsis indicates that health workers need to be alerted if babies born
to mothers with such delivery fall sick.
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